Efficacy, safety, pharmacokinetics, immunogenicity, and serum neutralizing activity of AZD7442 (tixagevimab-cilgavimab) in patients hospitalized with COVID-19: long-term results from the DisCoVeRy trial

Authors: Clément R. Massonnaud, Nathan Peiffer-Smadja, Pascal Poignard et al.
Publication: Clinical Microbiology and Infection
Published: Apr 1, 2026
Source: Crossref
Back to Search View Original Cite This Article

Related Articles

A Simplified Approach to Evaluate Retinal Blue Light Hazard Using the Correlated Color Temperature of LED Light Sources

Farough Mohammadian, Ahmad Mehri et al. - Oct 2121

Read More
Effects of Integrative Behavioral Couple Therapy on Infertility Self-efficacy, Dyadic Adjustment, and Sexual Satisfaction in Infertile Couples

Fatemeh Vazirnia, Javad Karimi et al. - Feb 2121

Read More
Mouse Tracking for Web Marketing: Enhancing User Experience in Web Application Software by Measuring Self-Efficacy and Hesitation Levels

Katerina Tzafilkou, Nicolaos Protogeros et al. - Jan 2114

Read More
It’s a Matter of Perspective: The Role of Aging Expectations and Self-Efficacy Towards Engagement in Healthy Lifestyles Among Older Adults

Johnny Julvesano Yao Jr - Sep 2109

Read More
Influence of Personal Teacher Efficacy on Selection of Teaching Methods in Secondary Schools in Kwale County, Kenya

Unknown - Jan 2106

Read More